bosutinib
- RxCUI
- 1307619
- RxNorm name
- bosutinib
- Term type
- IN
- Status
- Active
- Updated
- 2026-07-21 06:58:13
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102012
- Active start
- 102012
- Multiple ingredient
- NO
- Branded
- NO
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BOSULIF | BOSUTINIB | U.S. Pharmaceuticals | d5929f91-6496-4c0e-97e8-0bd524e15763 | 2026-05-28 | Warnings, Adverse reactions | BOSUTINIB |
| Bosutinib | BOSUTINIB | Dr. Reddy's Laboratories Inc. | cb7a8d1d-07c0-462d-960f-214d44705e76 | 2026-05-25 | Warnings, Adverse reactions | BOSUTINIB |
| Bosutinib | BOSUTINIB | Alembic Pharmaceuticals Limited | 8f3e9739-8ec1-4ea9-b1bc-185fd07d84e4 | 2026-05-22 | Warnings, Adverse reactions | BOSUTINIB |
| Bosutinib | BOSUTINIB | Alembic Pharmaceuticals Inc. | 2ea1617f-41d3-479a-87d5-177013d39193 | 2026-05-20 | Warnings, Adverse reactions | BOSUTINIB |
| BOSULIF | BOSUTINIB | Pfizer Laboratories Div Pfizer Inc | adc84ad5-a04d-4fee-9ba8-91f7abd928e3 | 2026-03-10 | Warnings, Adverse reactions | BOSUTINIB |
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | L01EA | BCR-ABL tyrosine kinase inhibitors | ATC1-4 | bosutinib | |
| FDASPL | N0000175605 | Kinase Inhibitor | EPC | has_epc | bosutinib |
| FDASPL | N0000020009 | Bcr-Abl Tyrosine Kinase Inhibitors | MOA | has_moa | bosutinib |
| MEDRT | D000814 | Aniline Compounds | CHEM | has_ingredient | bosutinib |
| MEDRT | D009570 | Nitriles | CHEM | has_ingredient | bosutinib |
| MEDRT | D011804 | Quinolines | CHEM | has_ingredient | bosutinib |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bosutinib |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bosutinib monohydrate |
| MEDRT | D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | DISEASE | may_treat | bosutinib |
| MEDRT | D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | DISEASE | may_treat | bosutinib monohydrate |
| MEDRT | N0000020001 | Tyrosine Kinase Inhibitors | MOA | has_moa | bosutinib |
| MEDRT | N0000020001 | Tyrosine Kinase Inhibitors | MOA | has_moa | bosutinib monohydrate |
| MEDRT | N0000175672 | Cellular Proliferation Alteration | PE | has_pe | bosutinib |
| MEDRT | N0000175672 | Cellular Proliferation Alteration | PE | has_pe | bosutinib monohydrate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | ATC | L01EA04 |
| CODES | DRUGBANK | DB06616 |
| CODES | SNOMEDCT | 703128001 |
| CODES | SNOMEDCT | 703586005 |
| CODES | USP | m7834 |
| CODES | VUID | 4031718 |
| SOURCES | Source | Anatomical Therapeutic Chemical |
| SOURCES | Source | Drug Bank |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |